138494-30-1

Upstream product

• 861816-92-4 3',5'-O-(1,1,3,3-tetraisopropyl-disiloxan-1,3-diyl)-2'-O-trimethylsilyl-N₄-(4-anisoyl)cytidine 

Downstream Products

• 138603-20-0 N-(1-{(2R,3R,4R,5R)-5-[Bis-(4-methoxy-phenyl)-phenyl-methoxymethyl]-3-[1-(2-chloro-ethoxy)-ethoxy]-4-hydroxy-tetrahydro-furan-2-yl}-2-oxo-1,2-dihydro-pyrimidin-4-yl)-4-methoxy-benzamide 
• 138603-22-2 3'-O-<(2-cyanoethyl)(diisopropylamino)phosphino>-5'-O-dimethoxytrityl-2'-O-<1-(2-chloroethoxy)ethyl>-N⁴-anisoylcytidine 
• 138494-29-8 N⁴-anisoyl-2'-O-<1-(2-chloroethoxy)ethyl>cytidine 
• 138494-34-5 Succinic acid mono-{(2R,3R,4R,5R)-2-[bis-(4-methoxy-phenyl)-phenyl-methoxymethyl]-4-[1-(2-chloro-ethoxy)-ethoxy]-5-[4-(4-methoxy-benzoylamino)-2-oxo-2H-pyrimidin-1-yl]-tetrahydro-furan-3-yl} ester 
• 861816-93-5 3',5'-O-(1,1,3,3-tetraisopropyl-disiloxan-1,3-diyl)-2'-O-(2-tetrahydrofuranyl)-N₄-(4-anisoyl)cytidine 

Relevant academic research and scientific papers

RIBONUCLEIC ACID COMPOUND AND METHOD OF LIQUID-PHASE SYNTHESIS OF OLIGONUCLEIC ACID COMPOUND

A novel phosphotriesterified ribonucleic acid compound which is important for liquid-phase synthesis of oligo-RNA is provided. Examples of the ribonucleic acid compound of the invention may include ribonucleic acid compounds represented by the following general formula: (wherein B represents adenine, guanine, cytosine or uracil or a modified form thereof; R21 represents aryl which may be substituted or a monocyclic or bicyclic heterocyclic group which may be substituted; R20 represents H or alkyl which may be substituted; and R1 represents a protecting group which can be removed at 90% or more at a temperature in the range from 0°C to 60°C under acidic conditions at a pH value from 2 to 4 within 24 hours).